Le Lézard
Classified in: Science and technology, Business
Subject: CON

Brixtel Defense Secures Prestigious Defense Contract for DCIS Ammunition Under DoD IG


Brixtel Defense is thrilled to announce its recent contract award to supply the Defense Criminal Investigative Service (DCIS) with critical 9mm and 5.56mm ammunition to NATO spec and Frangible training rounds under the oversight of the Department of Defense Inspector General (DoD IG).

GLENDIVE, Mont., April 23, 2024 /PRNewswire-PRWeb/ -- Washington, D.C. ? Brixtel Defense is thrilled to announce its recent contract award to supply the Defense Criminal Investigative Service (DCIS) with critical 9mm and 5.56mm ammunition to NATO spec and Frangible training rounds under the oversight of the Department of Defense Inspector General (DoD IG). This significant award underscores Brixtel Defense's commitment to providing high-quality, reliable solutions to our nation's defense sectors.

"This contract is a testament to our relentless dedication to supporting the security and operational readiness of our federal agencies," said Andrew Mansoor, CEO of Brixtel Defense.

 

"This contract is a testament to our relentless dedication to supporting the security and operational readiness of our federal agencies," said Andrew Mansoor, CEO of Brixtel Defense. "We are honored to be entrusted with such a critical supply chain role under the DoD IG."

 

Brixtel Defense is dedicated to upholding the highest standards of excellence and innovation in the defense industry, ensuring that our armed services are equipped with the best resources to fulfill their mission.

For more information about Brixtel Defense and our projects, please visit www.brixteldefense.com.

About Brixtel Defense: Brixtel Defense is a leading provider in the defense sector, known for its innovative solutions and commitment to quality. Serving the needs of military and federal agencies, Brixtel Defense ensures top-tier performance and reliability across all its products and services.

Media Contact

Marketing, Brixtel® Defense, 1 2026554080, [email protected], https://www.brixteldefense.com

SOURCE Brixtel® Defense


These press releases may also interest you

at 17:17
Ferrovial Completes Regulatory Review Process for Nasdaq Listing
Ferrovial SE ("Ferrovial" or the "Company"), one of the world's leading infrastructure companies, has concluded the U.S. regulatory review process for the Company's registration statement filed with the U.S. Securities and Exchange Commission (the...

at 17:05
Globalstar, Inc. Earnings Release and Call Notice
Globalstar, Inc. will announce its first quarter 2024 financial and operating results on Wednesday, May 8, 2024 after the market closes. The release will be available over the wire and from the Globalstar, Inc. website at www.globalstar.com. The...

at 17:05
AGF Reports April 2024 Assets Under Management and Fee-Earning Assets
AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of $47.8 billion as at April 30, 2024. AUM($ billions)April 30, 2024March 31,2024% ChangeMonth-Over-MonthApril 30,2023% ChangeYear-Over-YearTotal Mutual...

at 17:05
Global Helium Corp. Grants Stock Options
Global Helium Corp. ("HECO" or the "Company") is pleased to announce that, pursuant to the Company's stock option plan, it has granted incentive stock options to acquire up to 1,075,000 common shares of the Company to certain directors, officers and...

at 17:00
FG Acquisition Corp. Announces Proposed Acquisition of Strong/MDI Screen Systems, Inc. and launch of Saltire Holdings, Ltd.
FG Acquisition Corp. ("FGAC" or the "Corporation"), a special purpose acquisition company, and Strong Global Entertainment, Inc. ("Strong Global") are pleased to announce the proposed acquisition (the "MDI Acquisition") of Strong/MDI Screen...

at 17:00
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
Sentynl...

More news about Business...


News published on and distributed by: